These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35409410)

  • 21. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
    Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
    Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.
    Chen XM; Guo K; Li H; Lu QF; Yang C; Yu Y; Hou JW; Fei YD; Sun J; Wang J; Li YX; Li YG
    Heart Vessels; 2019 Jan; 34(1):177-188. PubMed ID: 30008122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1.
    Vyas B; Puri RD; Namboodiri N; Nair M; Sharma D; Movva S; Saxena R; Bohora S; Aggarwal N; Vora A; Kumar J; Singh T; Verma IC
    Am J Med Genet A; 2016 Jun; 170(6):1510-9. PubMed ID: 27041150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
    Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
    Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.
    Burgess DE; Bartos DC; Reloj AR; Campbell KS; Johnson JN; Tester DJ; Ackerman MJ; Fressart V; Denjoy I; Guicheney P; Moss AJ; Ohno S; Horie M; Delisle BP
    Biochemistry; 2012 Nov; 51(45):9076-85. PubMed ID: 23092362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
    Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions.
    Matavel A; Medei E; Lopes CM
    Channels (Austin); 2010; 4(1):3-11. PubMed ID: 19934648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LQT1-associated mutations increase KCNQ1 proteasomal degradation independently of Derlin-1.
    Peroz D; Dahimène S; Baró I; Loussouarn G; Mérot J
    J Biol Chem; 2009 Feb; 284(8):5250-6. PubMed ID: 19114714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
    Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
    J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation.
    Song Y; Guo T; Jiang Y; Zhu M; Wang H; Lu W; Jiang M; Qi M; Lan F; Cui M
    Stem Cell Res Ther; 2022 Jun; 13(1):287. PubMed ID: 35765105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel KCNQ1 splicing mutation in patients with forme fruste LQT1 aggravated by hypokalemia.
    Imai M; Nakajima T; Kaneko Y; Niwamae N; Irie T; Ota M; Iijima T; Tange S; Kurabayashi M
    J Cardiol; 2014 Aug; 64(2):121-6. PubMed ID: 24373870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the KCNQ1 gene mutation in 2 families with congenital long QT syndrome type 1 in Xinjiang Uygur Autonomous Region].
    Li YD; Maimaitiabudula M; Zhou XH; Lu YM; Zhang JH; Xing Q; Tang BP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):868-873. PubMed ID: 30462975
    [No Abstract]   [Full Text] [Related]  

  • 35. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
    Lee Y; Park H; Kyung Koo S; Kim JH
    Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.
    Spätjens RL; Bébarová M; Seyen SR; Lentink V; Jongbloed RJ; Arens YH; Heijman J; Volders PG
    Cardiovasc Res; 2014 Oct; 104(1):216-25. PubMed ID: 25139741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
    Schwartz PJ; Moreno C; Kotta MC; Pedrazzini M; Crotti L; Dagradi F; Castelletti S; Haugaa KH; Denjoy I; Shkolnikova MA; Brink PA; Heradien MJ; Seyen SRM; Spätjens RLHMG; Spazzolini C; Volders PGA
    Eur Heart J; 2021 Dec; 42(46):4743-4755. PubMed ID: 34505893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity.
    Giudicessi JR; Ackerman MJ
    Circ Cardiovasc Genet; 2013 Apr; 6(2):193-200. PubMed ID: 23392653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1).
    Wilson AJ; Quinn KV; Graves FM; Bitner-Glindzicz M; Tinker A
    Cardiovasc Res; 2005 Aug; 67(3):476-86. PubMed ID: 15935335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.